Sevoflurane Inhalation Anesthetic

Sevoflurane Inhalation Anesthetic
Product Description

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as aninhalational anaesthetic for induction and maintenance of general anesthesia.

Strength: 250ml.


Sevoflurane Inhalation Anesthetic was approved by NMPA and launched in Chinese market in 2007 which is used in the induction and maintenance of the general anesthetic of pediatric in-patient and out-patient surgery. In November 2015, it was approved by US FDA and launched in US market and in 2016 got the approval to get launched in EU (MA in Germany, Netherlands and Netherlands).

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    28523-86-6
  • Supplied from
    China

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Jiangsu Hengrui Medicine Co., Ltd. (29)

  • Irinotecan HCl

    Product Irinotecan HCl

    Irinotecan is a drug used for the treatment of cancer. Its main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen FOLFIRI, which consists of infusional 5-fluorouracil, leucovorin, and irinotecan.

    It is approved by NMPA....
  • Ketamine HCl

    Product Ketamine HCl

    Ketamine is a medication mainly used for starting and maintaining anesthesia. It induces a trance-like state while providing pain relief, sedation, and memory loss. Other uses include for chronic pain and for sedation in intensive care. Heart function, breathi...
  • Letrozole

    Product Letrozole

    Letrozole is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.

    It is approved by NMPA.
    It gets CEP certificate in Europe. It is also approved by US-FDA and Japanese PMDA.EDMF and USDMF are available.
    Current...
  • Mesna

    Product Mesna

    Mesna is an organosulfur compound. It is used therapeutically to reduce the incidence of haemorrhagic cystitis and haematuria when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy. These two anticancer agents, in vivo, may be converted to urotoxic metabol...
  • Olmesartan Medoxomil

    Product Olmesartan Medoxomil

    Olmesartan Medoxomil is an angiotensin II receptor antagonist which has been used for the treatment of high blood pressure.

    This API has got Chinese local GMP certificate.
  • Oxaliplatin

    Product Oxaliplatin

    Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy. It is used for treatment of colorectal cancer, typically along with folinic acid and 5-fluorouracil in a combination known as FOLFOX. Oxaliplatin has been compared with other platinum compo...
  • Desflurane for inhalation

    Product Desflurane for inhalation

    Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia.

    Strength: 240ml

    It is approved by NMPA.
    It is approved by US-FDA and EU.

  • Dexmedetomidine HCl Injection

    Product Dexmedetomidine HCl Injection

    Dexmedetomide HCl is an anxiolytic, sedative, andanalgesic medication.

    Strength: 200mcg/2ml (100mcg/ml); Single-dose Vial
    This product has been approved by CFDA and US-FDA.

    Strength: 80mcg/20ml; 200mcg/50ml; 400mcg/100ml
    This product has been approv...
  • Atracurium Besylate

    Product Atracurium Besylate

    Atracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation d...
  • Butorphanol Tartrate

    Product Butorphanol Tartrate

    Butorphanol Tartate is a morphinan-type synthetic opioid analgesic.

    It is approved by NMPA.
  • Salmeterol xinafoate + Fluticasone propionate

    Product Salmeterol xinafoate + Fluticasone propionate

    It is indicated for asthma.It is still in R&D stage.
  • Sugammadex Sodium

    Product Sugammadex Sodium

    Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults.It is still in R&D stage and estimated to be approved by 2020.

Jiangsu Hengrui Medicine Co., Ltd. resources (3)